Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Jul;20(6):669-678.
doi: 10.1177/17474930251317883. Epub 2025 Jan 28.

Efficacy and safety of mechanical thrombectomy in distal medium middle cerebral artery occlusion ischemic stroke patients on low-dose aspirin

Hamza Adel Salim  1   2 Vivek Yedavalli  1 Fathi Milhem  2 Basel Musmar  3 Nimer Adeeb  4 Motaz Daraghma  2 Kareem El Naamani  3 Nils Henninger  5 Sri Hari Sundararajan  6 Anna Luisa Kühn  7 Jane Khalife  8 Sherief Ghozy  9 Luca Scarcia  10 Benjamin Yq Tan  11   12 Robert W Regenhardt  2 Jeremy J Heit  13 Nicole M Cancelliere  14 Joshua D Bernstock  15 Aymeric Rouchaud  16 Jens Fiehler  17 Sunil Sheth  18 Ajit S Puri  7 Christian Dyzmann  19 Marco Colasurdo  20 Leonardo Renieri  21 João Pedro Filipe  22 Pablo Harker  23 Răzvan Alexandru Radu  24 Mohamad Abdalkader  25 Piers Klein  25 Thomas R Marotta  14 Julian Spears  14 Takahiro Ota  26 Ashkan Mowla  27 Pascal Jabbour  3 Arundhati Biswas  28 Frédéric Clarençon  29   30 James E Siegler  8 Thanh N Nguyen  25 Ricardo Varela  31 Amanda Baker  32 Muhammed Amir Essibayi  32 David Altschul  32 Nestor R Gonzalez  33 Markus A Möhlenbruch  34 Vincent Costalat  24 Benjamin Gory  35   36 Christian Paul Stracke  37 Constantin Hecker  38 Hamza Shaikh  8 Christoph J Griessenauer  38 David S Liebeskind  39 Alessandro Pedicelli  40 Andrea M Alexandre  40 Illario Tancredi  41 Tobias D Faizy  42 Erwah Kalsoum  10 Max Wintermark  43 Boris Lubicz  44 Aman B Patel  2 Vitor Mendes Pereira  14 Adrien Guenego  44 Adam A Dmytriw  2   14
Affiliations
Multicenter Study

Efficacy and safety of mechanical thrombectomy in distal medium middle cerebral artery occlusion ischemic stroke patients on low-dose aspirin

Hamza Adel Salim et al. Int J Stroke. 2025 Jul.

Abstract

Background: Acute ischemic stroke (AIS) from distal medium vessel occlusion (DMVO) presents unique treatment challenges. Mechanical thrombectomy (MT) is emerging as a viable option for these patients, yet the role of pre-stroke aspirin treatment is unclear. This study evaluates the impact of pre-stroke low-dose aspirin on outcomes in DMVO patients undergoing MT.

Methods: We conducted a multinational, multicenter, propensity score-weighted analysis within the Multicenter Analysis of primary Distal medium vessel occlusions: effect of Mechanical Thrombectomy (MAD-MT) registry. Patients with AIS due to DMVO, treated with MT, were included. We compared outcomes between patients on pre-stroke low-dose aspirin (75-100 mg) and those not on antiplatelet therapy. The primary outcome was functional independence at 90 days (modified Rankin Scale (mRS), 0-2). Secondary outcomes included excellent functional outcome at 90 days (mRS, 0-1), mortality, and day 1 post-MT National Institutes of Health Stroke Scale (NIHSS) score. Safety outcomes focused on hemorrhagic complications, including symptomatic intracerebral hemorrhage (sICH).

Results: Among 1354 patients, 150 were on pre-stroke low-dose aspirin. After applying inverse probability of treatment weighting (IPTW), aspirin use was associated with significantly better functional outcomes (mRS, 0-2: odds ratio (OR) = 1.89, 95% confidence interval (CI) = 1.14 to 3.12) and lower 90-day mortality (OR = 0.56, 95% CI = 0.32 to 1.00). The aspirin group had lower NIHSS scores on day 1 (β = -1.5, 95% CI = -2.8 to -0.27). The sICH rate was not significantly different between the groups (OR = 0.92, 95% CI = 0.60 to 1.43).

Conclusions: Pre-stroke low-dose aspirin was associated with improved functional outcomes and reduced mortality in patients with DMVO undergoing MT, without a significant increase in sICH. These findings suggest that low-dose aspirin may be safe and associated with more frequent excellent outcomes for this patient population. Further prospective studies are needed to validate these results and assess long-term outcomes.

Keywords: Acute ischemic stroke; aspirin; distal medium vessel occlusions; mechanical thrombectomy.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr Regenhardt serves on a DSMB for a trial sponsored by Rapid Medical, serves as site PI for studies sponsored by Penumbra and Microvention, and receives stroke research grant funding from the National Institutes of Health, Society of Vascular and Interventional Neurology, and Heitman Stroke Foundation. Dr Guenego reports consultancy for Rapid Medical and Phenox, not directly related to the present work. Dr Clarençon reports conflicts of interest with Medtronic, Balt Extrusion (consultant), ClinSearch (core lab), Penumbra, Stryker (payment for reading), and Artedrone (Board); all not directly related to the present work. Dr Henninger received support from NINDS NS131756, NINR NR020231, and NINDS NS113844 during the conduct of the study. All unrelated to the present work. Dr Liebeskind is consultant for Imaging Core Lab to Cerenovus, Genentech, Medtronic, Stryker, and Rapid Medical. Dr Griessenauer reports a proctoring agreement with Medtronic and research funding by Penumbra. Dr Nguyen reports Associate Editor of Stroke; advisory board of Brainomix, Aruna Bio. Dr Puri is a consultant for Medtronic Neurovascular, Stryker Neurovascular, Balt, Q’Apel Medical, Cerenovus, Microvention, Imperative Care, Agile, Merit, CereVasc, and Arsenal Medical; he received research grants from NIH, Microvention, Cerenovus, Medtronic Neurovascular, and Stryker Neurovascular and holds stocks in InNeuroCo, Agile, Perfuze, Galaxy, and NTI. Dr Jabbour is a consultant for Medtronic, Microvention, and Cerus. Dr Siegler has served as a consultant for AstraZeneca and has received funding from the National Institutes of Health (R61NS135583), Viz.ai, Philips, and Medtronic.

Similar articles

References

    1. Mei J, Salim HA, Lakhani DA, et al. Lower admission stroke severity is associated with good collateral status in distal medium vessel occlusion stroke. J Neuroimaging 2024; 34: 424–429. - PubMed
    1. Rehman S, Nadeem A, Kasi ABU, et al. Role of hypoperfusion intensity ratio in vessel occlusions: a review on safety and clinical outcomes. AJNR Am J Neuroradiol 2024; 46: 1069–1081. - PMC - PubMed
    1. Yedavalli V, Salim HA, Mei J, et al. Decreased quantitative cerebral blood volume is associated with poor outcomes in large core patients. Stroke 2024; 55: 2409–2419. - PubMed
    1. Lakhani DA, Balar AB, Salim H, et al. CT perfusion derived rCBV < 42% lesion volume is independently associated with follow-up FLAIR infarct volume in anterior circulation large vessel occlusion. Diagnostics (Basel) 2024; 14: 845. - PMC - PubMed
    1. Salim HA, Hamam O, Parilday G, et al. Relative cerebral blood flow as an indirect imaging surrogate in patients with anterior circulation large vessel occlusion and association of baseline characteristics with poor collateral status. J Am Heart Assoc 2024; 13: e034581. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources